The American Society of Clinical Oncology (ASCO) annual meeting is one of the largest gatherings of oncology professionals globally, and this year’s event showcased numerous…
Oncocyte Corporation’s (Nasdaq: OCX) VitaGraft TM Kidney diagnostic test for transplant monitoring has been successfully utilized in a Phase 2 clinical trial published in the…
Digested Read: Breakthroughs from DDW 2024
The human digestive system contains eight organs and has its own nervous system. It can be affected by our emotions and is ruled by a…
PRISM MarketView Commends US Military and Showcases Patriotic Stock Plays in Honor of Memorial Day Weekend
As Memorial Day weekend approaches, we must remember and honor those who have served and sacrificed for our country. We thank those who have dedicated…
What’s Next in the Great GLP-1 Race?
Roche Holding (RHHBY) joined the race to commercialize its own GLP-1 (glucagon-like peptide-1) receptor agonist drug this week, announcing that its dual-agonist asset, CT-388, had…
A Changing Landscape: AI In Biotechnology
The use of artificial intelligence (AI) in biotechnology offers companies a compelling opportunity to accelerate and optimize drug development, a process that is time consuming,…
The FDA approved 55 drugs in 2023, including the highly anticipated Lecanemab by Eisai (ESAIY) and Biogen (BIIB), GSK’s (GSK) world-first vaccine for respiratory syncytial…
Glioblastoma is a complex, aggressive brain cancer that has no cure. The median length of survival following diagnosis is between 15 and 18 months, and…
High Stakes: Seven Key Drug Trial Failures in 2024
The cost of developing a new drug – a process that can take between 10 and 15 years from concept to market – has risen…
As Tesla, Inc. (TSLA) continues to report dismal numbers and news, an ominous tone is being set for the EV market as most of the…
Advancing Vaccines for Cancer
Cancer was responsible for nearly 10 million deaths in 2020. Treatments for cancer, which represents a group of complex and diverse diseases, have been in…
If you are not a pet person and it’s not allergy related, we’d like to know what UFO you’re reading this from. Because who doesn’t…